Introduction
The initiation and regulation of adaptive immune responses are highly dependent on the activation state of dendritic cells (DCs). Dendritic cells can be activated by microbial and viral products (pathogen-associated molecular patterns or PAMPs), 1 which are recognized by pattern-recognition receptors (PRRs). Double-stranded (ds) RNA, a viral replication intermediate, acts as a molecular pattern and can bind to different PRRs. These include the subcellularly located Toll-like receptor (TLR) 3, 2 which can be activated following internalization of dsRNA by DCs, 3 and cytosolic receptors such as the dsRNA-dependent protein kinase (PKR), 4 ,5 2 0 -5 0 oligoadenylate synthetases 6 and the retinoic acid-inducible gene I (RIG-I). 7 Triggering of PRRs initiates signaling cascades that regulate the expression of a number of proteins including type I interferons (IFNs) and inflammatory cytokines and mediators. These molecules can promote DC activation in a paracrine or autocrine fashion. [8] [9] [10] [11] [12] When DCs are induced to mature by different stimuli, they share several features, such as an upregulation of major histocompatibility complex (MHC) and costimulatory molecules and an increased T-cell priming capacity. 8, [13] [14] [15] [16] However, the cytokines and inflammatory mediators produced by these activated DCs differ depending on which PRRs are triggered. This set of mediators will in turn determine both the extent and the type of T-cell expansion and effector differentiation. 17 In fact, the nature, intensity and duration of the activation signal determine the effector function of DCs. Therefore, it is essential to define the optimal activation signals that are necessary to convert immature or resting DCs into fully immunostimulatory or effector antigen-presenting cells (APCs). 18, 19 Because RNA electroporation has been shown to be an effective method for DC loading with antigens, we investigated whether the simultaneous electroporation of DCs with a dsRNA analogue and tumor antigen encoding mRNA could induce functional activation of DCs and whether these activated DCs were able to stimulate naïve CD8 + T cells in an antigen-specific manner. Poly(I:C 12 U) is a clinically approved, commercially available analogue of poly(I:C). Adams et al. 20 have recently demonstrated that in vitro culture of human monocyte-derived DCs in the presence of poly(I:C 12 U) can induce their maturation. In the present study, we show that human DCs activated by electroporation with poly(I:C 12 U) together with Melan-A/MART-1 (hereafter referred to as Melan-A) encoding mRNA were able to stimulate Melan-A-specific CTLs more efficiently than DCs matured by a cocktail of inflammatory cytokines.
Results

Electroporation with poly(I:C 12 U) induces dendritic cell maturation
We assessed whether DCs could be activated by electroporation with a dsRNA analogue without further treatment with maturation factors in the culture medium.
In preliminary experiments, we used commercially available research-grade poly(I:C). Electroporation of DCs with this reagent resulted in massive cell death, possibly because of endotoxin contamination (data not shown). Therefore, we decided to use endotoxin-free poly(I:C 12 U) for further experiments. Induction of maturation of immature DCs electroporated with increasing amounts of endotoxin-free poly(I:C 12 U) was evaluated by flow cytometry and by assessment of interleukin (IL)-12p70 secretion. Dendritic cells electroporated with amounts exceeding 0.5 mg poly(I:C 12 U) demonstrated phenotypic changes such as the upregulation of several surface markers ( Figure 1a ) and production of IL-12p70 ( Figure 1b) indicative of DC maturation. Electroporation with more than 2 mg poly(I:C 12 U) induced cell death (data not shown), whereas less than 0.5 mg poly(I:C 12 U) did not induce IL-12p70 production. For DC maturation by passive pulsing, a titration (between 5 and 600 mg/ml) of poly(I:C 12 U) was likewise performed (data not shown). Ultimately, 1 mg poly(I:C 12 U) was used for electroporation of DCs and 100 mg/ml poly(I:C 12 U) was used for passive pulsing of DCs in all subsequent experiments. To compare the extent of maturation, DCs were either electroporated or passively pulsed with poly(I:C 12 U) or incubated with a cocktail of inflammatory cytokines. Poly(I:C 12 U)-electroporated DCs induced a marked upregulation of CD80, CD86, CD83, MHC class I and class II to levels that were comparable to those induced by passive pulsing with poly(I:C 12 U) or by treatment with a cocktail of inflammatory cytokines ( Figure 2a) . As Diebold et al. 5 observed that nonplasmacytoid DCs can act as IFN-producing cells in response to dsRNA if the viral pattern crosses the plasma membrane, we investigated the cytokine profile of poly(I:C 12 U)-electroporated DCs. Electroporation of DCs with poly (I:C 12 U) induced the secretion of low but significant levels of both IFN-a (range, 200-2000 pg/ml) and IL12p70 (range, 40-700 pg/ml) in culture supernatants (Figure 2b ). In contrast, passive pulsing of DCs with poly(I:C 12 U) did not induce production of detectable levels of IFN-a but induced production of significantly higher levels of IL-12p70 (range, 300-2000 pg/ml) when compared with poly(I:C 12 U)-electroporated DCs. IL-6 and tumor necrosis factor (TNF)-a secretion was similar for DCs (range, 300-2000 pg/ml) matured with the different stimuli. Because of the presence of IL-6 and TNF-a in the cytokine cocktail used to induce DC maturation, their level could not be measured in the culture supernatant. Most of the cytokines were released during the first 24 h after treatment, with a peak between 8 and 24 h for IFN-a, IL-12p70 and IL-6, whereas TNF-a was mainly released during the first 8 h (data not shown). We next assessed the effect of poly(I:C 12 U) electroporation on the ability of DCs to stimulate a pool of allogeneic T cells. Dendritic cells activated by electroporation with poly (I:C 12 U) are as potent in inducing T-cell proliferation as DCs matured in the presence of poly(I:C 12 U) or an inflammatory cytokine cocktail ( Figure 2c ). As we have never seen significant functional implications of mRNA electroporation on DCs (data not shown), we decided to use untreated DCs as controls.
Dendritic cells electroporated with poly(I:C 12 U) and loaded with Melan-A peptide are highly potent inducers of CD8 + T lymphocytes A hallmark of mature DCs is their ability to stimulate naïve CD8 + T cells in an antigen-specific manner, a function critical for the induction of a productive antitumor immune response. In order to evaluate the CD8 + T-cell-stimulating capacity of DCs exposed to different maturation stimuli, autologous CD8 + T cells from healthy HLA-A2 + donors were stimulated with Melan-A-A2 peptide-loaded DCs matured by electroporation with poly(I:C 12 U) or by culturing in the presence of the inflammatory cytokine cocktail. After three weekly stimulations, the Melan-A-specific CD8 + T-cell response was measured. We observed that the fraction of Melan-A peptide tetramer + CD8 + T cells was consistently higher in the cocultures of the DCs activated by poly(I:C 12 U) electroporation compared to the DCs activated in the presence of the cytokine cocktail (Figure 3a) . We further evaluated the intracellular IFN-g content and the cytolytic activity of these activated CD8 + T cells. We found that DCs activated by poly(I:C 12 U) electroporation yielded higher numbers of IFN-g-producing cells com- À melanoma cell line 938-mel were lysed. As previous studies have shown that human monocyte-derived DCs passively pulsed with poly(I:C) induce stimulation of antigen-specific CD8 + T cells, 21 we also investigated the capacity of Melan-A-A2 peptideloaded DCs activated by passive pulsing with poly (I:C 12 U) to activate naïve CD8 + T cells. Expansion of antigen-specific CD8 + T cells in vitro was quantified by tetramer analysis, 7 days after the third stimulation. Similar numbers of tetramer + CD8 + T cells were induced by the peptide-loaded DCs either electroporated or cultured in the presence of poly(I:C 12 U). These DCs were also able to induce comparable numbers of antigenspecific IFN-g-secreting CD8
+ T cells (data not shown). In addition to CD8 + T-cell expansion and IFN-g secretion induced by either type of DCs, cytotoxic activity of the induced CTLs was evaluated. Both activation methods induced effector DCs with equal potency to activate naïve CTL precursors toward effector T cells (Figure 3d ). CTL induction by dsRNA-electroporated DCs A Michiels et al cell line 938-mel were spared. Cytotoxic T-lymphocytes generated by DCs activated in the presence of an inflammatory cytokine cocktail were unable to induce lysis of the Melan-A-expressing HLA-A2-matched melanoma cell line 1087-mel.
Dendritic cells co-electroporated with poly(I:C 12 U) and Melan-A encoding mRNA are able to migrate specifically in response to the CCR7 ligand CCL19 Prostaglandin E 2 is a critical component of the cytokine cocktail and is important for the expression of CCR7 as well as for the responsiveness of DCs to CCR7 ligands. 22, 23 We tested whether DCs co-electroporated with poly(I:C 12 U) and Melan-A encoding mRNA can migrate in response to the CCR7 ligand CCL19 (MIP-3b). Although the total number of DCs that migrated in response to CCL19 was lower for the DCs activated by electroporation with poly(I:C 12 U), on average they migrated to the same extent as DCs activated by exposure to a cocktail of inflammatory cytokines when the results were presented as chemotactic index, defined as the fold increase in cell migration in the presence of CCL19 compared to spontaneous migration ( Figure 5 ).
Discussion
In this study, we were able to induce maturation of human monocyte-derived DCs through electroporation Cr-release assay. Differences were not statistically significant.
CTL induction by dsRNA-electroporated DCs
A Michiels et al with the synthetic dsRNA analogue poly(I:C 12 U). We further show that combining poly(I:C 12 U) with Melan-A encoding mRNA for the electroporation of DCs effectively induces the generation of Melan-A-specific CD8 + T cells and their differentiation to effector cells. Double-stranded RNA is expressed during the replication of RNA viruses, and has long been recognized as a PAMP. 24 Passive pulsing of myeloid DCs with the synthetic dsRNA analogue, poly(I:C), results in triggering of TLR3. 2 Subsequently, it leads to increased protein synthesis, upregulation of MHC, adhesion and costimulatory molecules and a rapid production of IL-12. [15] [16] [17] However, as viral replication occurs within the host cell, we wanted to mimic intracellular dsRNA generated during viral replication by electroporating DCs with poly(I:C 12 U). Introduction of poly(I:C 12 U) into DCs by electroporation will most likely result in direct association between the dsRNA analogue and cytosolic receptors, 5, 7, 25, 26 leading to activation of cytoplasmic signaling events that regulate the expression of a number of proteins including type I IFN, proinflammatory cytokines and IFN-regulated genes. Recently, Kato et al. 26 showed in mice that RIG-I is essential for induction of type I IFNs after infection with RNA viruses in myeloid DCs. However, it is very likely that both pathways are activated in a coordinate manner to enhance immune responses. In contrast, plasmacytoid DCs use the TLR system rather than RIG-I for viral detection. 26 It has been described in mouse studies that conventional nonplasmacytoid DCs have the potential to produce IFN-a in response to dsRNA, if the viral pattern crosses the plasma membrane, although less efficiently than plasmacytoid DCs. 5 In this study, we confirm these results in the human setting. When comparing phenotypic maturation by examining the upregulation of several DC surface markers on DCs electroporated with poly(I:C 12 U) to that induced by passive pulsing with poly(I:C 12 U) or by exposure to a cocktail of inflammatory cytokines, the level of maturation was similar in all three CTL induction by dsRNA-electroporated DCs A Michiels et al cases. However, a different pattern in cytokine production was observed. Dendritic cells induced to mature by electroporation with poly(I:C 12 U) produced low but significant levels of IFN-a in culture supernatants in comparison to plasmacytoid DCs, which are the main producers of IFN-a. 27, 28 As expected, DCs passively pulsed with poly(I:C 12 U) secreted no IFN-a. We also saw an upregulation of the secretion of proinflammatory cytokines both by DCs electroporated and by DCs passively pulsed with poly(I:C 12 U). In contrast, DCs matured by the classical cocktail of inflammatory cytokines and PGE 2 produced neither IFN-a nor IL-12p70. 29 Consistent with the phenotypic changes, DCs induced to mature by different stimuli showed an increased capacity to act as stimulators in an allogeneic mixed lymphocyte reaction. To further determine whether poly(I:C 12 U) electroporation induces functional activation of DCs through a TLR3-, PKR-or RIG-I-dependent pathway, we want to utilize RNA interference to knock down TLR3, PKR or RIG-I expression.
As most tumor antigens are recognized as selfantigens, one of the main challenges in tumor immunology is to elicit an immune response that can break this inherent tolerance. Although electroporation of DCs with poly(I:C 12 U) clearly induces DC maturation, an important finding is that Melan-A peptide-loaded DCs matured by poly(I:C 12 U) electroporation are superior inducers of anti-Melan-A effector CD8 + T cells. When compared with inflammatory cytokine cocktail matured DCs, poly(I:C 12 U)-electroporated DCs stimulated the generation of higher numbers of Melan-A-specific effector T cells as assessed by both tetramer binding and IFN-g-secreting T cells. In addition, CD8 + T cells stimulated with poly(I:C 12 U)-electroporated DCs demonstrated significant lytic activity against melanoma cells expressing Melan-A. We further demonstrate that DC activation through electroporation or passive pulsing with poly(I:C 12 U) yields DCs with similar capacity to activate naïve CTL precursors toward potent effector T cells. Another important mechanism by which poly (I:C 12 U)-treated DCs may function to more effectively induce antigen-specific T-cell responses is by promoting expansion of CD4 + T helper (Th) cells and polarizing their response toward Th type 1 (Th1). Dendritic cells electroporated or cultured with poly(I:C 12 U) were superior in stimulating the proliferation and IFN-g production of allogeneic naïve CD4 + T cells compared to DCs matured in the presence of the cytokine cocktail (unpublished data).
We and others have shown that DCs can be efficiently electroporated with tumor antigen encoding mRNA 30 and that these APCs are able to induce an in vitro tumor antigen-specific T-cell response. [31] [32] [33] Because infection is a major trigger for immunity, we electroporated DCs with poly(I:C 12 U) together with Melan-A encoding mRNA. As compared with cytokine cocktail-matured DCs, DCs matured by poly(I:C 12 U) electroporation were equally potent in the presentation of antigen-derived epitopes. However, the latter induced higher numbers of tetramer + CD8 + T cells, which resulted in more extensive lysis of target cell lines. Our results clearly confirm that dsRNA behaves as a molecular pattern that can directly activate DCs and lead to activation of CD8 + T lymphocytes, thus triggering an adaptive immune response. In addition to electroporation with tumor antigen encoding mRNA together with maturation stimuli, recent studies demonstrated that co-electroporation of DCs with selected costimulatory molecules also improved the stimulation of antigen-specific CTLs and facilitated Th1 polarization of naïve CD4 + Th cells. 34, 35 Fundamental to the priming of T-cell immune responses is the migration of antigen-loaded DCs from the sites of infection toward the draining secondary lymphoid tissues. We observe that cytokine cocktail-matured DCs have an increased mobility compared to poly (I:C 12 U)-electroporated DCs, but that they migrate to the same extent in response to the CCR7 ligand CCL19. Although it has been described that, in addition to CCR7 expression, PGE 2 is essential to promote migration of mature DCs toward lymph node-directing chemokines, 22, 23 recent data demonstrated that PGE 2 is not required for functional maturation of DCs. 36 An efficient DC-based cancer vaccine must combine antigen delivery with an appropriate strategy for activating DCs. The use of poly(I:C 12 U) electroporation to induce DC maturation has several additional advantages with respect to clinical applications for DC-based tumor immunotherapy. The method presented in this manuscript to simultaneously deliver an activation signal and tumor antigen to the DCs might simplify the preparation of DCs used in clinical immunotherapy protocols against cancer or infectious diseases, and represents a promising strategy to enhance the DCmediated stimulation of antigen-specific CTLs. Exposure of DCs to several maturation signals, simultaneously or sequentially, may bring about maximal T-cell stimulatory capacity, implying that a combination of signals could further optimize DC activation in vitro and in vivo. Along these lines, recent studies indicate that combinations of toll-like receptor ligands such as the TLR3 ligand poly(I:C) with the TLR8 ligand R848 synergize to induce elevated and sustained IL-12 production, enhancing T-cell responses in vitro. 37, 38 Further investigation of whether treatment of DCs by poly(I:C 12 U) electroporation combined with the addition of TLR ligands might enhance the induction of tumor-specific CTL responses is thus warranted. 
Materials and methods
Cell lines and tumor-infiltrating lymphocytes
In vitro generation of monocyte-derived dendritic cells
Peripheral blood mononuclear cells (PBMCs) were used as a source of DC precursors, and isolated from buffy coat preparations or leukapheresis products of healthy HLA-A2 + donors. Both the generation and the cryopreservation of immature DCs were previously described. 33 Briefly, monocytes were enriched in tissue culture flasks (Falcon, Becton Dickinson, San Jose, CA, USA) or in a semiclosed culture system using Cell Factories (NUNC, Naperville, IL, USA). The adherent fraction was cultured in RPMI 1640 medium or X-VIVO 20 medium (Cambrex) supplemented with 1% heat-inactivated autologous plasma (AP), PS, AAG, 1000 U/ml granulocyte macrophage-colony stimulating factor (GM-CSF) (prepared inhouse) and 100 U/ml IL-4 (BruCells, Brussels, Belgium). On days 2 and 4 of culture, fresh medium containing the same cytokine amounts as on day 0 was added. On day 6, immature DCs were harvested and cryopreserved in liquid nitrogen until further use.
Induction of dendritic cell maturation
Immature DCs were thawed and matured by electroporation with variable amounts (between 0.1 and 2 mg) of the dsRNA polymer poly(I:C 12 U) (Ampligen s ; Bioclones, Sandton, South Africa), by adding 100 mg/ml poly(I:C 12 U) to the culture medium (passive pulsing) or by adding an inflammatory cytokine cocktail containing 1000 U/ml IL-6 (prepared in-house), 100 U/ml IL-1b (prepared in-house), 100 U/ml TNF-a (Beromun, Boehringer Ingelheim Pharma, Germany) and 1 mg/ml PGE 2 (Sigma-Aldrich, St Louis, MO, USA) at a cell density of 1 Â 10 6 /ml in RPMI 1640 medium supplemented with 1% AP, PS, AAG, 1000 U/ml GM-CSF and 100 U/ml IL-4. Phenotype and function of DCs were assessed 24 h after induction of maturation. Before in vitro stimulation of naïve CD8 + T cells, DCs were loaded with the indicated peptide at 24 h after induction of maturation. In some experiments, DCs were used as stimulator cells after electroporation with the Melan-A encoding mRNA. Dendritic cells that were left immature were used as controls. All in-house-prepared cytokines were animal protein-free, endotoxin-free and biologically active, and were titrated against standards obtained from the National Institute for Biological Standards and Control (NIBSC, South Mimms, UK). In some experiments, poly(I:C) purchased from Sigma (lot 074K4047, endotoxin content: 450 IU/mg, as determined by the Limulus Amebocyte Lysate Assay from Cambrex) was used.
Cloning of cDNA constructs
The plasmid pGEM-sig-Melan-Amut-DCLamp1 encoding Melan-A with an A27L amino acid (aa) mutation for optimal binding affinity with HLA-A*0201 and recognition by T cells 39 was created by in situ mutagenesis (GeneEditort in vitro Site-Directed Mutagenesis System, Promega, Madison, WI USA) of cloned wild-type Melan-A using an oligonucleotide containing the desired DNA mutation. The production of in vitro-transcribed capped mRNA was previously described. 33 Integrity and purity were routinely tested for in vitro-synthesized mRNA.
Electroporation of dendritic cells
Immature DCs or cytokine cocktail-matured DCs were electroporated with RNA by an optimized protocol. [31] [32] [33] Briefly, after two wash steps, 8 Â 10 6 DCs were resuspended in a final volume of 200 ml Optimix Solution B (EQUIBIO, Ashford, UK) containing the RNA. Electroporation was performed in a 4 mm gap cuvette using the EQUIBIO EasyjecT Plus s apparatus (EQUIBIO). The following conditions were used for all electroporations: voltage 300 V, capacitance 150 mF and resistance 99 O, resulting in a pulse time of about 5 ms. Immediately after electroporation, DCs were diluted to a final density of 1 Â 10 6 /ml in RPMI 1640 medium supplemented with 1% AP, PS, AAG, 1000 U/ml GM-CSF and 100 U/ml IL-4 for 24 h. When Melan-A encoding mRNA was co-electroporated with poly(I:C 12 U) into immature DCs or electroporated into cytokine cocktail-matured DCs, 20 mg mRNA was used. Dendritic cells electroporated with Melan-A encoding mRNA were used as stimulator cells at 24 h (electroporated in an immature state) or 48 h (electroporated in a mature state) after induction of maturation.
Synthetic peptides and peptide pulsing
The lyophilized synthetic peptides corresponding to the optimized Melan-A immunodominant epitope (Melan-A-A2 peptide, A27L, aa 26-35, sequence ELAGIGILTV; a kind gift from Dr P van der Bruggen, Ludwig Institute, Brussels, Belgium) and the gag epitope (gag-A2 peptide; HXB2 gag peptide-complete Set, NIH, AIDS Research & Reference Reagent Program, McKesson BioServices Corporation, Rockville, MD, USA), both HLA-A2 restricted, were dissolved in 100% dimethylsulfoxide (Sigma) at 20 mg/ml, further diluted in 10 mM acetic acid to a final concentration of 2 mg/ml, and stored in aliquots at À201C. Dendritic cells induced to mature by different stimuli or T2 cells were loaded with 10 mg/ml of the indicated peptide at a cell density of 2 Â 10 6 /ml in serum-free RPMI 1640 medium and incubated for 2 h at 371C. HLA class I-restricted peptide pulsing was supplemented with 2.5 mg/ml b2-microglobulin (purchased from Calbiochem, Darmstadt, Germany and dissolved at 250 mg/ml PBS and stored at À201C).
Flow cytometry
Human DCs were stained using monoclonal antibodies (mAbs) against CD25, CD40, CD80, CD83, CD86, HLA ABC, CCR7 (all from BD PharMingen, San Jose, CA, USA) and HLA-DR (purified from clone L243; prepared in-house). All antibodies (Abs) were phycoerythrin-(PE) labeled except for anti-HLA-ABC, which was fluorescein isothiocyanate-(FITC) labeled, anti-CCR7, which was incubated with a biotin-labeled rat anti-mouse immunoglobulin M mAb (BD PharMingen) and subsequently detected through streptavidin-PE (BD PharMingen), and anti-HLA-DR, which was biotin-labeled with detection through streptavidin-PE. Nonreactive isotype-matched Abs (BD PharMingen) were used as controls. Data were collected using a FACSCalibur flow cytometer (Becton Dickinson). Data were analyzed using CellQuest software (Becton Dickinson). Cells were electronically gated according to light scatter properties in order to exclude dead and contaminating cells.
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Quantification of cytokine production
For evaluation of the ability of DCs to produce cytokines after induction of maturation by different stimuli, culture supernatants were collected after 24 h and stored at À801C until further use. The concentrations of IFN-a, IL-12p70 (both Bender MedSystems, Vienna, Austria), IL-6 and TNF-a (both eBioscience, San Diego, CA, USA) concentrations were assessed using commercially available enzyme-linked immunosorbent assay (ELISA) kits.
Allostimulatory capacity of dendritic cells
An allogeneic mixed lymphocyte reaction was performed to evaluate the ability of DCs that were either electroporated with 1 mg poly(I:C 12 U), passively pulsed with 100 mg/ml poly(I:C 12 U) or exposed to a cocktail of inflammatory cytokines to stimulate a pool of allogeneic T cells. Briefly, nonadherent cells (2 Â 10 5 ) collected from freshly isolated PBMCs and subsequently stored in liquid nitrogen were thawed and cocultured with DCs (24 h after induction of maturation) at a responder-tostimulator ratio of 30:1 in 96-well round-bottom plates for 5 days. The proliferation assay was carried out in RPMI 1640 medium supplemented with 1% AP, PS and AAG. For the last 16 h of coculture, 1 mCi 3 H-methylthymidine (Amersham, Buckingham, UK) was added. Untreated immature DCs were used as negative controls. Cells were harvested on glass filter paper and thymidine uptake was quantified by liquid scintillation counting (Microbeta, Wallac, Turku, Finland).
Migration assay
Chemotaxis of DCs electroporated with Melan-A encoding mRNA either together with poly(I:C 12 U) or after maturation using the cytokine cocktail was measured by assessing migration through a polycarbonate filter with 5 mm pore size in 24-well Transwell chambers (Corning Costar, Elscolab, Belgium) as previously described. 33 Briefly, 600 ml of RPMI 1640 medium containing 1% AP, PS, AAG with 40 ng/ml CCL19 (MIP-3b; R&D Systems, Oxford, UK) or medium without CCL19 for spontaneous migration was added to the lower chamber. A total of 1 Â 10 5 DCs were added to the upper chamber in a volume of 100 ml. After an incubation period of 1.5 h at 371C, the medium in the lower chamber was harvested and concentrated to a volume of 200 ml and the number of migrated DCs was counted by flow cytometry acquiring events for a fixed time period of 60 s. Immature DCs electroporated with Melan-A encoding mRNA were used as a negative control.
Antigen presentation assay
To analyze the T-cell stimulatory capacity of DCs electroporated with Melan-A encoding mRNA either together with poly(I:C 12 U) or after maturation using the cytokine cocktail, DCs (2 Â 10 ) purified using magneticactivated cell sorting (Miltenyi Biotec, Bergisch Gladbach, Germany) in a six-well plate containing 5 ml IMDM medium supplemented with 1% AP, PS and AAG. After 3 days, 20 U/ml IL-2 and 10 ng/ml IL-7 (PeproTech, London, UK) were added to the coculture. CD8 + T cells were restimulated weekly with the same stimulator DCs as used in the primary stimulation. Seven days after the third stimulation, CD8 + T cells were harvested, washed and their antigen specificity and function were analyzed.
Analysis of Melan-A peptide HLA-A2 tetramer + CD8
+ T cells
A PE-labeled HLA-A2 tetramer loaded with the Melan-A immunodominant peptide (prepared in-house), in combination with a FITC-labeled anti-CD8 human mAb (BD PharMingen), was used for extracellular staining of in vitro-primed CD8 + T cells. As a negative control, a PE-labeled HLA-A2 tetramer loaded with a MAGE-A3 peptide (aa 271-279, sequence FLWGPRALV) (prepared in-house), in combination with a FITC-labeled anti-CD8 human mAb, was used. The tetramers were used at a concentration of 10 nM. All stainings were conducted at 41C for 15 min and subsequently evaluated by flow cytometry.
Analysis of antigen-specific interferon-g release by intracellular staining
Melan-A-specific effector function of in vitro-stimulated CD8 + T cells was evaluated using intracellular IFN-g staining according to the manufacturer's instructions (BD Biosciences). Briefly, T2 cells pulsed with Melan-A-A2 peptide (stimulator cells) were incubated with primed CD8 + T cells (responder cells) at a stimulatorto-responder ratio of 1:10 for 3 h at 371C. Irrelevant gag-A2 peptide-pulsed T2 cells were used as control stimulator cells. Golgi-Plug (brefeldin A) was then added to block IFN-g secretion and the cells were incubated for an additional 10 h at 371C. CD8 + T cells were stained using anti-CD8-FITC mAb for 30 min at 41C. After washing, cells were fixed, permeabilized and intracellular staining for IFN-g-PE was performed. Interferon-g production by CD8
+ T cells was analyzed by flow cytometry.
Cytotoxicity assay
To determine the cytotoxic activity of primed CD8 maximum release were determined in the presence of medium or 10% sodium dodecyl sulfate, respectively. Spontaneous release was always o20% of maximum release.
Statistical analysis
Results are represented as mean7s. 
